We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+4.34%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.69B
AUM Growth
-$77.2M
Cap. Flow
-$122M
Cap. Flow %
-7.21%
Top 10 Hldgs %
19.67%
Holding
509
New
80
Increased
151
Reduced
135
Closed
101

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$94.7M
2
CGNX icon
Cognex
CGNX
+$22.8M
3
BIIB icon
Biogen
BIIB
+$9.81M
4
TRU icon
TransUnion
TRU
+$9.41M
5
NCLH icon
Norwegian Cruise Line
NCLH
+$9.33M

Sector Composition

Rank Sector Weight
1 Healthcare 31.24%
2 Technology 24.62%
3 Consumer Discretionary 13.94%
4 Financials 6.61%
5 Industrials 6.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APPN icon
251
Appian
APPN
$1.74B
$1.05M 0.06%
29,092
-29,834
-51% -$1.02M
WMS icon
252
Advanced Drainage Systems
WMS
$10.9B
$1.04M 0.06%
31,722
-5,778
-15% -$167K
CARB
253
DELISTED
Carbonite Inc
CARB
$1.04M 0.06%
39,900
-7,300
-15% -$178K
DESP
254
DELISTED
Despegar.com
DESP
$1.03M 0.06%
74,400
+32,400
+77% +$443K
WOR icon
255
Worthington Enterprises
WOR
$2.76B
$1.03M 0.06%
41,543
+20
+0% +$469
LKFN icon
256
Lakeland Financial Corp
LKFN
$1.52B
$987K 0.06%
21,076
-1,000
-5% -$46.6K
AMAG
257
DELISTED
AMAG Pharmaceuticals
AMAG
$967K 0.06%
96,842
+24,842
+35% +$268K
NTLA icon
258
Intellia Therapeutics
NTLA
$1.5B
$954K 0.06%
+58,288
New +$916K
APLS
259
DELISTED
Apellis Pharmaceuticals
APLS
$936K 0.06%
36,920
+8,520
+30% +$173K
LAB icon
260
Standard BioTools
LAB
$326M
$922K 0.05%
74,838
+38
+0.1% +$484
SPNT icon
261
SiriusPoint
SPNT
$2.98B
$916K 0.05%
88,800
+14,319
+19% +$153K
MGEE icon
262
MGE Energy Inc
MGEE
$3.11B
$911K 0.05%
12,462
LXRX icon
263
Lexicon Pharmaceuticals
LXRX
$1.02B
$897K 0.05%
142,600
-28,646
-17% -$171K
PGNX
264
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$863K 0.05%
139,900
-12,300
-8% -$59.3K
OSUR icon
265
OraSure Technologies
OSUR
$273M
$860K 0.05%
+92,700
New +$853K
SSP icon
266
E.W. Scripps
SSP
$274M
$847K 0.05%
55,404
+4
+0% +$75
OFG icon
267
OFG Bancorp
OFG
$2.21B
$842K 0.05%
35,412
+12
+0% +$239
CNNE icon
268
Cannae Holdings
CNNE
$647M
$838K 0.05%
28,900
-4,100
-12% -$108K
NVMI
269
Nova
NVMI
$13.9B
$837K 0.05%
32,700
-800
-2% -$21.4K
NEX
270
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$829K 0.05%
123,309
-5,720
-4% -$53.5K
VSTO
271
DELISTED
Vista Outdoor Inc.
VSTO
$827K 0.05%
93,100
+22,628
+32% +$194K
LMNX
272
DELISTED
Luminex Corp
LMNX
$813K 0.05%
39,402
+10,517
+36% +$231K
BANC icon
273
Banc of California
BANC
$3.28B
$787K 0.05%
56,300
+2,766
+5% +$39.1K
MBI icon
274
MBIA
MBI
$288M
$785K 0.05%
84,310
+264
+0.3% +$2.46K
CHEF icon
275
Chefs' Warehouse
CHEF
$3.87B
$759K 0.04%
21,634
+11
+0.1% +$362

Similar funds

PDT Partners's Q2 2019 Portfolio in Review

As of Q2 2019, PDT Partners held 509 positions worth $1.69B, down 4.4% from $1.77B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

PDT Partners withdrew a net $122M in Q2 2019, closing 101 positions and reducing 135 holdings. Its most notable exit was Amazon, an estimated $30.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in AbbVie worth $87.6M.

  • PDT Partners's largest Q2 2019 buy was AbbVie: 1,205,251 shares worth $87.6M.
  • PDT Partners added most to Block Inc in Q2 2019, an estimated $8.46M increase.
  • PDT Partners's biggest Q2 2019 reduction was American International, cutting an estimated $7.38M.
  • PDT Partners fully exited Amazon in Q2 2019, selling an estimated $30.6M.
  • PDT Partners's ten largest holdings make up 20% of its $1.69B portfolio in Q2 2019.
  • PDT Partners opened 80 new positions and closed 101 in Q2 2019.
  • PDT Partners's portfolio value fell 4.4% quarter-over-quarter to $1.69B.

Based on PDT Partners's 13F filing for Q2 2019, filed 14 Aug 2019.